Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

What is DVA's Selling, General, and Administrative (SG&A)?

  DaVita Inc ( DVA ) |
1996 - 2021 (26 years)

Selling, General, and Administrative (SG&A) is 
$1.2B (1Y +1.13% )

DVA Stock Price & Selling, General, and Administrative (SG&A)

Selling, General, and Administrative (SG&A) for DVA competitors.
LPNT NXTM FMS HNGR UHS LH MD THC
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Selling, General, and Administrative (SG&A)

chevron_right 2021 $585.9M +28.4x
( +13.9% / year avg)
chevron_left 1996 $19.9M
vertical_align_top Peak $1.6B +78.6x
vertical_align_bottom Bottom $19.9M
arrow_drop_up # Up Years 19 19 of 26
years up.
arrow_drop_down # Down Years 7
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • DVA's stock price has rallied +2,104% from $4.08 in 1996 , or +0.71x the rate relative to it's selling, general, and administrative (sg&a) over the same period.
  • If DVA grows it's stock at the same rate as it's selling, general, and administrative (sg&a) (+13.9%/year) , it's stock price will grow +367% and hit $330.15 over the next 10 years.
  • DVA's stock price has gone up 14 of the 19 years (+73%) it's selling, general, and administrative (sg&a) were also up.
  • DVA Historical Selling, General, and Administrative (SG&A) Table
    in $ million
    Year Selling, General, and Administrative (SG&A) YoY % Change Stock Price YoY % Change (Stock Price)
    4/1/2021 $585 -52.0% $89.84 0.0%
    4/1/2020 $1,221 11.7% $89.84 25.2%
    4/1/2019 $1,093 -3.4% $71.77 8.6%
    4/1/2018 $1,132 -22.4% $66.06 8.2%
    4/1/2017 $1,459 -7.9% $61.06 -3.6%
    4/1/2016 $1,585 12.9% $63.35 -13.3%
    4/1/2015 $1,403 14.6% $73.04 -4.6%
    4/1/2014 $1,224 15.7% $76.53 28.5%
    4/1/2013 $1,057 18.3% $59.55 10.3%
    4/1/2012 $894 36.4% $54.0 41.8%
    4/1/2011 $655 17.4% $38.09 4.8%
    4/1/2010 $558 -1.1% $36.35 22.7%
    4/1/2009 $564 -13.6% $29.62 17.9%
    4/1/2008 $653 6.3% $25.12 -18.9%
    4/1/2007 $615 12.4% $30.98 16.4%
    4/1/2006 $547 100.1% $26.6 1.4%
    4/1/2005 $273 25.1% $26.24 58.0%
    4/1/2004 $218 13.6% $16.61 30.5%
    4/1/2003 $192 15.6% $12.73 48.9%
    4/1/2002 $166 31.4% $8.55 13.2%
    4/1/2001 $126 -34.1% $7.55 114.4%
    4/1/2000 $192 17.0% $3.52 128.4%
    4/1/1999 $164 36.6% $1.54 -84.8%
    4/1/1998 $120 214.1% $10.15 23.0%
    4/1/1997 $38 92.5% $8.25 15.4%
    4/1/1996 $19 - $7.15 -

  • About
    Industry: Medical Care Facilities
    Sector: Healthcare
    Country: US
    IPO Date: 10/31/1995
    Stonk Exchange: NYSE
    • DaVita, Inc
    • engages in the provision of medical care services.
    • The company is headquartered in Denver, Colorado and currently employs 77,700 full-time employees.
    • The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
    • The firm's segments include U.
    • S
    • dialysis and related lab services and Other-Ancillary services and strategic initiatives.
    • Its U
    • S
    • dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD).
    • In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

  • Selling, general and administrative expense (SG&A) is reported on the income statement as the sum of all direct and indirect selling expenses and all general and administrative expenses (G&A) of a company. SG&A, also known as SGA, includes all the costs not directly tied to making a product or performing a service. That is, SG&A includes the costs to sell and deliver products and services and the costs to manage the company.

    For more detailed definitions, please see Investopedia.